Filing Details

Accession Number:
0001209191-17-052897
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-14 21:25:00
Reporting Period:
2017-09-12
Accepted Time:
2017-09-14 21:25:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Aduro Biotech Inc. ADRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193201 T Stephen Isaacs C/O Aduro Biotech, Inc.
740 Heinz Avenue
Berkeley CA 94710
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-12 82,100 $0.00 186,125 No 4 A Direct
Common Stock Disposition 2017-09-13 12,204 $10.99 173,921 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 70,657 Indirect By Family Trust
Footnotes
  1. Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017.
  2. The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
  3. The shares are owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee.